FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

306 letters match. Newest first.

  1. Greenway Herbal Products LLC

    FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.

    High risk
  2. Princess Lifestyles, LLC

    FDA warns Princess Lifestyles over unapproved drug claims, CGMP failures, and ephedrine-alkaloid supplement Stomaisu.

    High risk
  3. Bea Lydecker’s Naturals, Inc.

    FDA says Bea Lydecker’s Naturals marketed supplements and CBD products as unapproved drugs for diseases.

    High risk
  4. Vital Health & Wellness

    FDA says Vital Health & Wellness sold Holy Tea as an unapproved drug with disease-treatment claims.

    Low
  5. rxshopmd.com

    FDA warned rxshopmd.com, a Cyprus website, for selling unapproved and misbranded drugs, including lopinavir/ritonavir, to U.S. consumers online.

    High risk
  6. Extrapharmacy.ru

    FDA warned Extrapharmacy.ru for selling unapproved, mislabeled prescription drugs, including COVID-19 treatments, to U.S. consumers online.

    High risk
  7. CytoDyn, Inc.

    FDA warns CytoDyn over video promoting unapproved leronlimab as safe and effective for COVID-19.

    High risk
  8. Pharmacy2Home/LandiCom Holding LTD

    FDA warned Pharmacy2Home/LandiCom Holding LTD over unapproved, mislabeled drugs sold online with COVID-19 claims.

    High risk
  9. Glenn Burkett Naples Corporation

    Glenn Burkett Naples Corporation sold colloidal silver and supplement products as unapproved drugs, including claims to treat COVID-19.

    High risk
  10. GeroNova Research Inc.

    FDA warned GeroNova Research that disease claims on its Amazon store and social media make its carnitine and R-lipoic acid supplements unapproved, misbranded drugs.

    Medium
  11. Apothecary Health Solutions/Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

    FDA cited Carie Boyd's Prescription Shop for compounded drugs that failed outsourcing-facility labeling and reporting rules.

    Medium
  12. Wholly Liquid Nutritional Supplements LLC

    FDA says Wholly Liquid’s supplement website claims make seven products unapproved new drugs and misbranded.

    Low
  13. Synaptent, LLC

    FDA warned Synaptent, LLC over website claims that make its supplement products unapproved new drugs and misbranded.

    Medium
  14. LIV Health LLC dba INFINIWELL and DEAL Media L.L.C. dba HARMONIA

    FDA warned LIV Health/INFINIWELL and DEAL Media/HARMONIA that seven products were sold as unapproved new drugs via disease-treatment claims.

    High risk
  15. Saffron Health Sciences

    FDA warned Saffron Health Sciences that Crocin Rich supplements were unapproved new drugs promoted with disease and COVID-19 claims.

    High risk
  16. Advanced Nutriceuticals, LLC dba The Guyer Institute of Molecular Medicine

    Advanced Nutriceuticals compounded sterile drugs without required prescriptions and under insanitary conditions, FDA says.

    High risk
  17. Quicksilver Scientific

    FDA warned Quicksilver Scientific that website claims made four products unapproved new drugs and misbranded.

    Low
  18. Dominant Nutrition LLC formerly 8 Weeks Out Labs

    FDA warned Dominant Nutrition that LipogenX is adulterated and website claims make three products unapproved drugs.

    High risk
  19. New Green Nutrition, Inc.

    FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.

    High risk
  20. Organa International Corp.

    FDA warned Organa International that it sold colloidal minerals, tea, and silver gel as unapproved drugs using disease claims on its website.

    High risk
  21. The Camel Milk Co. LLC dba Camel Culture

    FDA warned The Camel Milk Co. over camel milk products marketed as drugs to treat COVID-19, autism, and other conditions.

    High risk
  22. ICA Health, LLC/Future Formulations, LLC

    ICA Health sells five Dr. Wilson supplements with website claims that make them unapproved new drugs, FDA says.

    Medium
  23. Walfer Corporation dba The Medicine Shoppe Pharmacy

    FDA warned The Medicine Shoppe Pharmacy in Port Charlotte, Florida, over insanitary compounding conditions, vermin, and drugs made without valid prescriptions.

    High risk
  24. Supplement Science Corp. d/b/a Condemned Labz

    FDA warned Condemned Labz that five supplement products were unapproved new drugs and misbranded, and two were adulterated.

    High risk
  25. Holographic Health, Inc.

    FDA says Holographic Health marketed 14 products as unapproved new drugs through disease claims on its website.

    High risk
  26. Blue Poppy Enterprises Inc

    Blue Poppy Enterprises sold herbal products with disease-treatment claims as unapproved new drugs, FDA says.

    High risk
  27. Nanomateriales Químicos Avanzados, S.A. de C.V.

    FDA found Mexican maker Nanomateriales' ZANILAST hand sanitizer labeled 65% ethanol contained 1-propanol, with quality and labeling violations.

    High risk
  28. Fibromyalgia Treatment Group - FTG, LLC

    FDA warned Fibromyalgia Treatment Group that its Fibrolief, Nerve Renew and other supplements are unapproved new drugs sold with disease-treatment claims.

    High risk
  29. New York Nutrition Company / American Metabolix

    FDA says New York Nutrition/American Metabolix sold supplements with unapproved drug claims and unsafe additives Hordenine HCl and Higenamine HCl.

    High risk
  30. Brilliant Enterprises LLC

    FDA warned Brilliant Enterprises that its mushroom products are unapproved new drugs because website and social media claims say they treat diseases.

    Medium
  31. Pharmaganics LLC

    FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.

    High risk
  32. Phytag Labs

    FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.

    Medium
  33. Nuturna International LLC

    Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.

    High risk
  34. Metamune Inc

    FDA and FTC warn Metamune over DiabetesSupport supplement claims to treat diabetes without approval.

    High risk
  35. Live Good Inc.

    Live Good Inc. sold Berry Gen Sugar Control supplements as a diabetes treatment without FDA approval, making it an unapproved, misbranded drug.

    High risk
  36. Radhanite, LLC d/b/a Curalife Ltd

    FDA and FTC say Curalife markets CuraLin supplement with unapproved diabetes-treatment claims.

    High risk
  37. Aceva, LLC

    Aceva, LLC marketed Sugar Balance supplement with unapproved diabetes and blood sugar drug claims, FDA says.

    High risk
  38. Ar-Rahman Pharm LLC

    FDA and FTC cite Ar-Rahman Pharm for Diabetes Support sold with unapproved diabetes-treatment claims.

    High risk
  39. Lysulin, Inc.

    Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.

    High risk
  40. Holistic Healer & Wellness Center, Inc.

    FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.

    High risk
  41. Genesis Nutrition Ultra Slim dba Genesis Ultra Slim

    Genesis Nutrition Ultra Slim sells Genesis Ultra Slim Gold, a weight-loss product that contains undeclared sibutramine and phenolphthalein.

    High risk
  42. 247rxpill.in

    FDA warned website 247rxpill.in for selling unapproved opioid and benzodiazepine drugs to U.S. consumers.

    High risk
  43. PowerAll Pharma

    FDA warned PowerAll Pharma for selling unapproved, misbranded opioid and benzodiazepine drugs online without prescriptions.

    High risk
  44. AnazaoHealth Corporation

    AnazaoHealth Corporation compounded drugs without meeting 503B conditions, including inadequate adverse event reporting.

    Medium
  45. Pharmaceutical Care Solutions dba Pharmacy Solutions

    FDA warns Pharmaceutical Care Solutions dba Pharmacy Solutions over compounded drugs made with ineligible bulk substances and lacking FDA approval.

    Medium
  46. Je Dois Lavoir LLC

    Je Dois Lavoir sells 365 Skinny High Intensity weight-loss drug containing undeclared sibutramine without FDA approval.

    High risk
  47. TeaTaze, LLC

    TeaTaze marketed eight teas with claims they treat diseases, including COVID-19, making them unapproved new drugs, FDA says.

    High risk
  48. 1st Phorm LLC

    FDA warned 1st Phorm that its heart supplements were unapproved drugs and some supplements contained unsafe hordenine.

    High risk
  49. Chill6

    FDA told drink maker Chill6 its amino acid beverage is an unapproved new drug sold for anxiety and contains an unsafe additive.

    High risk
  50. 3RD Day Nutraceuticals, LLC

    FDA says 3rd Day Nutraceuticals marketed four supplements as unapproved drugs with disease claims on its website.

    Low